Giant Cell Tumors: Clinical Trials

5 trials for Giant Cell Tumors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 active not recruiting. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Recruiting 2, Active not recruiting 1

Follow Giant Cell Tumors: new trials by email Literature Review of Giant Cell Tumors trials Research Report on Giant Cell Tumors

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery
Indocyanine Green - Giant Cell Tumor of Bone
Phase 4RecruitingShanghai Jiao Tong University Affiliated Sixth People's Hospital402026-01-022026-01-05
Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery
Indocyanine Green - Tenosynovial Giant Cell Tumor
Phase 4RecruitingShanghai Jiao Tong University Affiliated Sixth People's Hospital402026-01-022026-01-05
Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
XGEVA® - Giant Cell Tumor of Bone
Phase 4Active not recruitingAmgen362023-08-172025-10-01
Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib
Pexidartinib - Tenosynovial Giant Cell Tumor
Phase 4CompletedDaiichi Sankyo322020-10-202024-12-30
Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004
Denosumab - Giant Cell Tumor of Bone
Phase 4CompletedAmgen852017-11-132024-05-20

Narrower conditions

Giant Cell Tumor of Bone (3)  ·  Giant Cell Tumor of Tendon Sheath (2)

Broader conditions

Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms, Connective Tissue (5)  ·  Neoplasms, Connective and Soft Tissue (5)  ·  Neoplasms, Bone Tissue (3)  ·  Joint Diseases (2)  ·  Muscular Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Synovitis (2)  ·  Tendinopathy (2)

Interventions

Denosumab (2)  ·  Indocyanine Green (2)  ·  pexidartinib (1)

Sponsors

Amgen (2)  ·  Shanghai Jiao Tong University Affiliated Sixth People's Hospital (2)  ·  Daiichi Sankyo (1)

Countries

China (3)  ·  Australia (2)  ·  Italy (2)  ·  Spain (2)  ·  Taiwan (2)  ·  United States (2)  ·  France (1)  ·  Hungary (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Sweden (1)  ·  United Kingdom (1)

Results publications

PMID 21613624, PMID 31188797, PMID 32224746, PMID 37121591, PMID 37178368, PMID 17013643, PMID 28057477, PMID 29290809, PMID 33094400, PMID 33214476, PMID 33754215, PMID 35230489, PMID 35837703, PMID 36502615, PMID 37121582

NIH funding

2017 (1)